All this drawdown has made me realize I don't hold anything in healthcare. So I started buying LLY this past month and now this week started getting into GENB.
$LLY - solid long-term stock, kind of overvalued in a P/E to EV/EBITDA sense compared to its market comparables, but if you look at its PEG ratio due to its huge growth, it feels fairly priced. Big player has a lot of room to grow in the fat-loss industry as it goes international. Also, a great pipeline in the mental health sector. Great investments into AI to accelerate drug discovery.
GENB - NVDIA bought into this stock a while ago, at around $12.80, now that the stock has had a drawdown and sits around $13.5, I have started buying a small position DCA until I see some upward momentum. Great AI play, as we can tell by NVDIA investment. Good runway with enough cash to survive 2 years. Some revenue already, FDA pipeline, for an Asma product that might turn them profitable. Looks good for a speculative play/value for what it is.